Drug discovery and biotechnology in Germany

Drug discovery and biotechnology in Germany
Download Download Drug discovery and biotechnology in Germany (2.1mb)

The pharmaceutical marketplace is changing significantly with huge challenges ahead for the industry and biotech as a whole. The major socioeconomic trends expected to have most impact can be summarised as follows: increases in chronic disease due to the demographic shift; the health care payers' influence on how doctors prescribe with impending talks on pay for performance, and the growth of emerging markets and demand for innovative medicines. In addition, many governments are beginning to focus on prevention, which will create new opportunities in drug discovery.

To get a clearer understanding of the great potential and opportunities offered by biotechnology-based drug discovery, PwC carried out an investigation of the German landscape of drug discovery and biotechnology together with the Council of German BioRegions.